The Association of Systemic Microvascular Changes with Lung Function and Lung Density: A Cross-Sectional Study

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Harris, Bianca ^a   Klein, Ronald ^b   Jerosch Herold, Michael ^c,d   Hoffman, Eric A ^e   Ahmed, Firas S ^a   Jacobs, David R ^f,g   Klein, Barbara E K ^b   Wong, Tien Y ^h,i   Lima, Joao A C ^j   Cotch, Mary Frances ^k   Barr, R Graham ^a,l  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g UNIVERSITY OF OSLO   (Norway)

^h UNIVERSITY OF MELBOURNE   (Australia)

ⁱ NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^j JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k NATIONAL EYE INSTITUTE   (United States)

^l Mailman School of Public Health   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE;

ADULT; AGED; ARTERIOLE; ARTICLE; ATHEROSCLEROSIS; BODY SIZE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ETHNICITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEART BLOOD VESSEL; HEART MUSCLE BLOOD FLOW; HEART PERFUSION; HUMAN; HUMAN TISSUE; KIDNEY BLOOD VESSEL; LUNG DENSITY; LUNG FIELD; LUNG FUNCTION; MAGNITUDE ESTIMATION METHOD; MAJOR CLINICAL STUDY; MALE; MICROVASCULARIZATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; RESPIRATORY TRACT PARAMETERS; RETINA BLOOD VESSEL; SMOKING; SPIROMETRY; URINALYSIS;

EID: 84871415200     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050224     Document Type: Article

References (62)

1. Miniño AM, Murphy SL, Xu J, Kochanek KD, (2011) Deaths: final data for 2008. Natl Vital Stat Rep 59 (10):: 1-126.
2. Forey BA, Thornton AJ, Lee PN, (2011) Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med 11 (36):: 1-61.
3. Rennard SI, Vestbo J, (2008) Natural histories of chronic obstructive pulmonary disease. Proc Am Thorac Soc 5: 878-883.
4. Di Stefano A, Capelli A, Lusuardi M, Balbo P, Vecchio C, et al. (1998) Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 158: 1277-1285.
5. Pesci A, Balbi B, Majori M, (1998) Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J 12: 380-386.
6. Michaud SE, Dussault S, Groleau J, Haddad P, Rivard A, (2006) Cigarette smoke exposure impairs VEGF-induced endothelial cell migration: Role of NO and reactive oxygen species. J Mol Cell Cardiol 41: 275-284.
7. O'Rourke MF, Safar ME, (2005) Relationship between aortic stiffening and microvascular disease in brain and kidney: Cause and logic of therapy. Hypertension 46: 200-204.
8. Gooding KM, Tooke JE, von Lany H, Mitra M, Ling R, et al. (2010) Capillary pressure may predict preclinical changes in the eye. Diabetologia 53: 2029-2035.
9. Yoshida T, Tuder RM, (2007) Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev 87 (3):: 1047-1082.
10. Giordano RJ, Lahdenranta J, Zhen L, Chukwueke U, Petrache I, et al. (2008) Targeted induction of lung endothelial cell apoptosis causes emphysema-like changes in the mouse. J Biol Chem 283 (43):: 29447-29460.
11. Schweitzer KS, Hatoum H, Brown MB, Gupta M, Justice MJ, et al. (2011) Mechanisms of lung endothelial barrier disruption induced by cigarette smoke: role of oxidative stress and ceramides. Am J Physiol Lung Cell Mol Physiol 301 (6):: L836-L846.
12. Damico R, Simms T, Kim BS, Tekeste T, Amankwan H, et al. (2011) P53 mediates cigarette smoke-induced apoptosis of pulmonary endothelial cells inhibitory effects of macrophage migration inhibitor factor. Am J Respir Cell Mol Biol 44 (3):: 323-332.
13. Nana-Sinkam SK, Lee JD, Sotto-Santiago S, Stearman RS, Keith RL, et al. (2007) Prostacyclin prevents pulmonary endothelial cell apoptosis induced by cigarette smoke. Am J Respir Crit Care Med 175 (7):: 676-685.
14. Sharma J, Young DM, Marentette JO, Rastogi P, Turk J, et al. (2012) Lung endothelial cell platelet-activating factor production and inflammatory cell adherence are increased in response to cigarette smoke component exposure. Am J Physiol Lung Cell Mol Physiol 302: L47-L55.
15. Barr RG, Mesia-Vela S, Austin JH, Basner RC, Keller BM, et al. (2007) Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: The Emphysema and Cancer Action Project (EMCAP) Study. Am J Respir Crit Care Med 176: 1200-1207.
16. Eickhoff P, Valipour A, Kiss D, Schreder M, Cekici L, et al. (2008) Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 178 (12):: 1211-1218.
17. Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, et al. (2010) Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 362: 217-227.
18. Alford SK, van Beek EJ, McLennan G, Hoffman EA, (2010) Heterogeneity of pulmonary perfusion as a mechanistic image-based phenotype in emphysema susceptible smokers. Proc Natl Acad Sci U S A 107 (16):: 7485-7490.
19. Gordon C, Gudi K, Krause A, Sackrowitz R, Harvey BG, et al. (2011) Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. Am J Respir Crit Care Med 184: 224-232.
20. Takahashi T, Kobayashi S, Fujino N, Suzuki T, Ota C, et al. (2012) Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility. Thorax doi:10.1136/thoraxjnl-2011-201395.
21. Wang JJ, Liew G, Klein R, Rochtchina E, Knudtson MD, et al. (2007) Retinal vessel diameter and cardiovascular mortality: pooled data analysis from two older populations. Eur Heart J 28: 1984-1992.
22. McGeechan K, Liew G, Macaskill P, Irwig L, Klein R, et al. (2009) Meta-analysis: Retinal vessel caliber and risk for coronary heart disease. Ann Intern Med 151: 404-413.
23. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, et al. (2001) Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286: 421-426.
24. Hillege HL, Fidler V, Diercks GF, van Gilst W, de Zeeuw D, et al. (2002) Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106: 1777-1782.
25. Hallan S, Astor B, Romundstad S, Aasarød K, Kvenild K, et al. (2007) Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Arch Intern Med 167 (22):: 2490-2496.
26. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, et al. (2002) Abnormal subendocardial perfusion in Cardiac Syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 346: 1948-1953.
27. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, et al. (2002) Multi-Ethnic Study of Atherosclerosis: Objectives and design. Am J Epidemiol 156: 871-881.
28. Barr RG, Ahmed FS, Carr JJ, Hoffman EA, Jiang R, et al. (2012) Subclinical atherosclerosis: airflow obstruction and emphysema: the MESA Lung Study. Eur Respir J 39 (4):: 846-854.
29. Hankinson J, Odencrantz J, Fedan K, (1999) Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 159: 179-187.
30. Wong TY, Islam FM, Klein R, Klein BE, Cotch MF, et al. (2006) Retinal vascular caliber, cardiovascular risk factors, and inflammation: The Multi-Ethnic Study of Atherosclerosis (MESA). Invest Ophthalmol Vis Sci 47: 2341-2350.
31. Kramer H, Jacobs DR Jr, Bild D, Post W, Saad MF, et al. (2005) Urine albumin excretion and subclinical cardiovascular disease. The Multi-Ethnic Study of Atherosclerosis. Hypertension 46: 38-43.
32. Wang L, Jerosch-Herold M, Jacobs DR Jr, Shahar E, Folsom AR, (2006) Coronary risk factors and myocardial perfusion in asymptomatic adults: The Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 47: 565-572.
33. Jerosch-Herold M, Swingen C, Seethamraju RT, (2002) Myocardial blood flow quantification with MRI by model-independent deconvolution. Med Phys 29: 886-897.
34. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al. (2005) Standardisation of spirometry. Eur Respir J 26: 319-338.
35. Hankinson JL, Kawut SM, Shahar E, Smith LJ, Stukovsky KH, et al. (2010) Performance of American Thoracic Society-recommended spirometry reference values in a multiethnic sample of adults: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study. Chest 137: 138-145.
36. Carr JJ, Nelson JC, Wong ND, McNitt-Gray M, Arad Y, et al. (2005) Calcified coronary artery plaque measurement with cardiac CT in population-based studies: Standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) Study. Radiology 234: 35-43.
37. Hu S, Hoffman EA, Reinhardt JM, (2001) Automatic lung segmentation for accurate quantitation of volumetric x-ray CT images. IEEE Trans Med Imaging 20: 490-498.
38. Coxson HO, Mayo JR, Behzad H, Moore BJ, Verburgt LM, et al. (1995) Measurement of lung expansion with computed tomography and comparison with quantitative histology. J Applied Physiol 79: 1525-1530.
39. Reddy S, Barr RG, Berbaum K, McLennan G, van Bee E, et al. (2005) Quantitative evaluation of emphysema presence and distribution via coronary calcium CT compared with full lung study. Abstract presented at the International Conference of the Radiological Society of North America.
40. Hoffman EA, Jiang R, Baumhauer H, Brooks MA, Carr JJ, et al. (2009) Reproducibility and validity of lung density measures from cardiac CT scans-the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study. Acad Radiol 16: 689-699.
41. Ferris BG, (1978) Epidemiology standardization project. Am Rev Respir Dis 118 (Supp 2):: 1-120.
42. Rodriguez J, Jiang R, Johnson WC, MacKenzie BA, Smith LJ, et al. (2010) The association of pipe and cigar use with cotinine levels, lung function, and airflow obstruction: A cross-sectional study. Ann Intern Med 152: 201-210.
43. Bakke PS, Rönmark E, Eagan T, Pistelli F, Annesi-Maesano I, et al. (2011) Recommendations for epidemiological studies on COPD ERS Task Force Report. Eur Respir J 38 (6):: 1261-1277.
44. Rothman KJ, (1990) No adjustments are needed for multiple comparisons. Epidemiology 1: 43-46.
45. Wong TY, Klein R, Couper DJ, Cooper LS, Shahar E, et al. (2001) Retinal microvascular abnormalities and incident stroke: The Atherosclerosis Risk in Communities Study. Lancet 358: 1134-1140.
46. Nguyen TT, Wang JJ, Sharrett AR, Islam FM, Klein R, et al. (2008) Relationship of retinal vascular caliber with diabetes and retinopathy: The Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 31: 544-549.
47. Ozer T, Altin R, Ugurbas SH, Ozer Y, Mahmutyazicioglu K, et al. (2006) Color Doppler evaluation of the ocular arterial flow changes in chronic obstructive pulmonary disease. Eur J Radiol 57: 63-68.
48. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, et al. (1993) Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42: 801-813.
49. Chester AH, Borland JA, Buttery LD, Mitchell JA, Cunningham DA, et al. (1998) Induction of nitric oxide synthase in human vascular smooth muscle: Interactions between proinflammatory cytokines. Cardiovasc Res 38: 814-821.
50. Nguyen TT, Islam FM, Farouque HM, Klein R, Klein BE, et al. (2010) Retinal vascular caliber and brachial flow-mediated dilation: The Multi-Ethnic Study of Atherosclerosis. Stroke 41: 1343-1348.
51. Stehouwer CD, Smulders YM, (2006) Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms. J Am Soc Nephrol 17: 2106-2111.
52. Polatli M, Cakir A, Cildag O, Bolaman AZ, Yenisey C, et al. (2008) Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation. J Thromb Thrombolysis 26: 97-102.
53. Casanova C, de Torres JP, Navarro J, Aguirre-Jaime A, Toledo P, et al. (2010) Microalbuminuria and hypoxemia in patients with COPD. Am J Respir Crit Care Med 182 (8):: 1004-1010.
54. Chandra D, Stamm JA, Palevsky PM, Leader JK, Fuhrman CR, et al. (2012) The relationship between pulmonary emphysema and kidney function in smokers. Chest 142 (3):: 656-662.
55. Mehrotra PP, Weaver YJ, Higginbotham EA, (1983) Myocardial perfusion defect on thallium-201 imaging in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol 2: 233-239.
56. Calabrese C, Bocchino V, Vatrella A, Marzo C, Guarino C, et al. (2006) Evidence of angiogenesis in bronchial biopsies of smokers with and without airway obstruction. Respir Med 100: 1415-1422.
57. Zanini A, Chetta A, Saetta M, Baraldo S, Castagnetti C, et al. (2009) Bronchial vascular remodelling in patients with COPD and its relationship with inhaled steroid treatment. Thorax 64: 1019-1024.
58. Hashimoto M, Tanaka H, Abe S, (2005) Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD. Chest 127: 965-972.
59. Soltani A, Reid DW, Sohal SS, Wood-Baker R, Weston S, et al. (2010) Basement membrane and vascular remodelling in smokers and chronic obstructive pulmonary disease: A cross-sectional study. Respir Res 11: 105.
60. Mendes ES, Campos MA, Wanner A, (2006) Airway blood flow reactivity in healthy smokers and in ex-smokers with or without COPD. Chest 129: 893-898.
61. Seimetz M, Parajuli N, Pichl A, Veit F, Kwapiszewska G, et al. (2011) Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice. Cell 147: 293-305.
62. Hancock DB, Eijgelsheim M, Wilk JB, Gharib SA, Loehr LR, et al. (2010) Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet 42: 45-52.